How many clinical trials are tracked of rozanolixizumab?

8 trials are tracked, 4 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

rozanolixizumab

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of rozanolixizumab

8 trials tracked of rozanolixizumab: 4 in phase 3 or 4 and 4 with published results. The most-cited published study has 258 citations.

8Trials tracked

4Phase 3 & 4

0Recruiting

4With published results

Phase distribution

Phase 3 4 Phase 2 3 Phase 1 1

Phase 3 A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis Completed · 258 cited
Phase 3 A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis Completed · 255 cited
Phase 3 A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis Completed · 255 cited
Phase 3 A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG) Completed · 1 cited
Phase 2 A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome Completed
Phase 2 A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Completed

Show 2 more trials

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.